US Stock MarketDetailed Quotes
TPST Tempest Therapeutics
- 2.850
- -0.060-2.06%
Close Jun 18 16:00 ET
- 3.980
- +1.130+39.65%
Post 19:59 ET
63.32MMarket Cap-1656P/E (TTM)
3.000High2.830Low939.31KVolume2.920Open2.910Pre Close3.10MTurnover5.28%Turnover RatioLossP/E (Static)22.22MShares9.77052wk High3.07P/B50.69MFloat Cap0.17052wk Low--Dividend TTM17.79MShs Float260.100Historical High--Div YieldTTM5.84%Amplitude0.170Historical Low3.302Avg Price1Lot Size
Tempest Therapeutics Stock Forum
Sign in to post a comment
$Tempest Therapeutics(TPST.US$
You better have a good trial result Thursday and run 500%. Don’t ruin my post Holiday mood![]()
![]()
You better have a good trial result Thursday and run 500%. Don’t ruin my post Holiday mood
5
3
$Tempest Therapeutics(TPST.US$ Dont hit 4 before close or i have no choice but to hope for a pullback Thursday morning! hehehe
2
4
2
7
! You’re very welcome!$Tempest Therapeutics(TPST.US$ Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma
7 MINUTES AGO, 6:22 PM EDT
VIA GLOBENEWSWIRE
BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage biotechnology company developing first-in-classitargeted and immune-mediated therapeutics to fight cancer, today announced the company plans to report new data fr...
7 MINUTES AGO, 6:22 PM EDT
VIA GLOBENEWSWIRE
BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage biotechnology company developing first-in-classitargeted and immune-mediated therapeutics to fight cancer, today announced the company plans to report new data fr...
1
4
$Tempest Therapeutics(TPST.US$ ph interesting
$Tempest Therapeutics(TPST.US$ in a day of red, TPST was that little green I needed today.
$Tempest Therapeutics (TPST.US)$ Here is why OCGN will skyrocket 400% to 800% over the next 9 to 12 months.
What is OCU400's market potential? If we take Ocugen's estimates seriously, it is mouthwatering. The biotech projects that OCU400 could earn approval in 2026. Ocugen thinks the therapy could generate between $30 billion and $47 billion in total revenue in the five years after approval. The company's market cap is about $488 million as of this writing. So by any standard, if these projecti...
What is OCU400's market potential? If we take Ocugen's estimates seriously, it is mouthwatering. The biotech projects that OCU400 could earn approval in 2026. Ocugen thinks the therapy could generate between $30 billion and $47 billion in total revenue in the five years after approval. The company's market cap is about $488 million as of this writing. So by any standard, if these projecti...
9
$Tempest Therapeutics(TPST.US$ am I the only one holding out hope for a C&H on the 4hr
3
1
$Tempest Therapeutics (TPST.US)$ this has been the bottom 3 times before. Any move below this would definitely be a big buy in my book. But I wouldn't rush in over a few cent. If it breaks here, it would be a major break of structure and will resume its falling knife agenda. Otherwise history says this is the spot......
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
romeo guard : 500% is greedy
Jaguar8OP romeo guard: Well you will be greedy if you stay long and don’t secure profits. Hoping for 500% is not greedy, but staying even if it is not realistic during trading is greedy. That is altogether different. Fix your mindset
romeo guard Jaguar8OP: Yes